Among commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.
Eberechukwu Onukwugha, PhD, MS
Advertisement
Articles by Eberechukwu Onukwugha, PhD, MS
Advertisement
Latest Updated Articles
- Rehospitalizations and Direct Medical Costs for cSSSI: Linezolid Versus Vancomycin
Published: December 13th 2013 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Fall 2025 Quiz: Test Your Pharmacy Knowledge!
2
FDA Approves Elinzanetant as First Nonhormonal Therapy for Menopause Vasomotor Symptoms
3
Lynkuet Access Program Aims to Help Women Save on Neurokinin-Targeted Therapy
4
High Non-HDL-C/HDL-C Ratio in Adults With Obesity Increases Depression Risk
5
